Latest news
Loading news…
Timberlyne Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Diego, California, United States Founded 2024 11-50 employees For Profit
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Patents granted
- 0
- Trademarks
- 0
- IT spend
- $163.11K
Company Info
- Founded
- 2024
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 7
- HQ
- San Diego, California, United States
- Region
- Greater San Diego Area, West Coast, Western US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -1.4
- Trend (90d)
- -0.5
Key People at Timberlyne Therapeutics
Chief Executive Officer
VP, Business Operations & Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Timberlyne Therapeutics
Loading news…
FAQs about Timberlyne Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.